• Publications
  • Influence
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units.
BACKGROUND There is controversy about how to manage requests by patients or surrogates for treatments that clinicians believe should not be administered. PURPOSE This multisociety statementExpand
  • 290
  • 13
  • PDF
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic Society (ATS)/EuropeanExpand
  • 149
  • 9
  • PDF
Validation of case-mix measures derived from self-reports of diagnoses and health.
Self-reported chronic diseases and health status are associated with resource use. However, few data exist regarding their ability to predict mortality or hospitalizations. We sought to determineExpand
  • 160
  • 8
Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer.
BACKGROUND We sought to examine health care resource utilization in the last 6 months of life among patients who died with chronic obstructive pulmonary disease (COPD) compared with those who diedExpand
  • 204
  • 7
  • PDF
Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study.
PURPOSE Lung cancer is the leading cause of cancer-related mortality among women. The role of hormone replacement therapy (HRT) in lung cancer development is unclear. PATIENTS AND METHODS WeExpand
  • 123
  • 7
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease
BackgroundAdministrative data is often used to identify patients with chronic obstructive pulmonary disease (COPD), yet the validity of this approach is unclear. We sought to develop a predictiveExpand
  • 98
  • 7
Patient-physician communication about end-of-life care for patients with severe COPD
Since patients with chronic obstructive pulmonary disease (COPD) infrequently discuss treatment preferences about end-of-life care with physicians, the goal of the present study was to identify whichExpand
  • 242
  • 6
Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
Context Many think we need more information about the safety of respiratory medications for chronic obstructive pulmonary disease (COPD). Contribution This large casecontrol study examinedExpand
  • 179
  • 6
  • PDF
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation.
RATIONALE The role of pulmonary function before stem cell transplant as a potential risk factor for the development of early post-transplant respiratory failure and mortality is controversial. Expand
  • 79
  • 6
Adherence to Long-Acting Inhaled Therapies among Patients with Chronic Obstructive Pulmonary Disease (COPD)
Abstract Background: Long-acting inhaled medications are an important component of the treatment of patients with chronic obstructive pulmonary disease (COPD), yet few studies have examined theExpand
  • 68
  • 6
...
1
2
3
4
5
...